• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗锥虫药氯尼达明可抑制布氏锥虫己糖激酶1。

The anti-trypanosomal agent lonidamine inhibits Trypanosoma brucei hexokinase 1.

作者信息

Chambers Jeremy W, Fowler Matthew L, Morris Meredith T, Morris James C

机构信息

Department of Genetics and Biochemistry, Clemson University, Clemson, SC 29634, United States.

出版信息

Mol Biochem Parasitol. 2008 Apr;158(2):202-7. doi: 10.1016/j.molbiopara.2007.12.013. Epub 2008 Jan 3.

DOI:10.1016/j.molbiopara.2007.12.013
PMID:18262292
Abstract

Glycolysis is essential to the parasitic protozoan Trypanosoma brucei. The first step in this metabolic pathway is mediated by hexokinase, an enzyme that transfers the gamma-phosphate of ATP to a hexose. The T. brucei genome (TREU927/4 GUTat10.1) encodes two hexokinases (TbHK1 and TbHK2) that are 98% identical at the amino acid level. Our previous efforts have revealed that TbHK2 is an important regulator of TbHK1 in procyclic form parasites. Here, we have found through RNAi that TbHK1 is essential to the bloodstream form parasite. Silencing the gene for 4 days reduces cellular hexokinase approximately 60% and leads to parasite death. Additionally, we have found that the recombinant enzyme is inhibited by lonidamine (IC(50)=850 microM), an anti-cancer drug that targets tumor hexokinases. This agent also inhibits HK activity from whole parasite lysate (IC(50)=965 microM). Last, lonidamine is toxic to cultured bloodstream form parasites (LD(50)=50 microM) and procyclic form parasites (LD(50)=180 microM). Interestingly, overexpression of TbHK1 protects PF parasites from lonidamine. These studies provide genetic evidence that TbHK1 is a valid therapeutic target while identifying a potential molecular target of the anti-trypanosomal agent lonidamine.

摘要

糖酵解对于寄生原生动物布氏锥虫至关重要。该代谢途径的第一步由己糖激酶介导,这是一种将ATP的γ-磷酸基团转移至己糖的酶。布氏锥虫基因组(TREU927/4 GUTat10.1)编码两种己糖激酶(TbHK1和TbHK2),它们在氨基酸水平上有98%的同一性。我们之前的研究表明,在原循环型寄生虫中,TbHK2是TbHK1的重要调节因子。在此,我们通过RNA干扰发现,TbHK1对于血流型寄生虫至关重要。使该基因沉默4天会使细胞己糖激酶减少约60%,并导致寄生虫死亡。此外,我们发现重组酶受到氯尼达明(IC(50)=850微摩尔)的抑制,氯尼达明是一种靶向肿瘤己糖激酶的抗癌药物。该药物也抑制全寄生虫裂解物中的HK活性(IC(50)=965微摩尔)。最后,氯尼达明对培养的血流型寄生虫(LD(50)=50微摩尔)和原循环型寄生虫(LD(50)=180微摩尔)有毒性。有趣的是,TbHK1的过表达可保护原循环型寄生虫免受氯尼达明的影响。这些研究提供了遗传学证据,表明TbHK1是一个有效的治疗靶点,同时确定了抗锥虫药物氯尼达明的一个潜在分子靶点。

相似文献

1
The anti-trypanosomal agent lonidamine inhibits Trypanosoma brucei hexokinase 1.抗锥虫药氯尼达明可抑制布氏锥虫己糖激酶1。
Mol Biochem Parasitol. 2008 Apr;158(2):202-7. doi: 10.1016/j.molbiopara.2007.12.013. Epub 2008 Jan 3.
2
Activity of a second Trypanosoma brucei hexokinase is controlled by an 18-amino-acid C-terminal tail.布氏锥虫第二种己糖激酶的活性受一个18个氨基酸的C末端尾巴调控。
Eukaryot Cell. 2006 Dec;5(12):2014-23. doi: 10.1128/EC.00146-06. Epub 2006 Oct 6.
3
Quercetin, a fluorescent bioflavanoid, inhibits Trypanosoma brucei hexokinase 1.槲皮素,一种荧光类黄酮,可抑制布氏锥虫己糖激酶 1。
Exp Parasitol. 2011 Feb;127(2):423-8. doi: 10.1016/j.exppara.2010.10.011. Epub 2010 Nov 11.
4
A target-based high throughput screen yields Trypanosoma brucei hexokinase small molecule inhibitors with antiparasitic activity.基于靶标的高通量筛选得到具有抗寄生虫活性的布氏锥虫己糖激酶小分子抑制剂。
PLoS Negl Trop Dis. 2010 Apr 13;4(4):e659. doi: 10.1371/journal.pntd.0000659.
5
Residues in an ATP binding domain influence sugar binding in a trypanosome hexokinase.ATP结合结构域中的残基影响锥虫己糖激酶中的糖结合。
Biochem Biophys Res Commun. 2008 Jan 18;365(3):420-5. doi: 10.1016/j.bbrc.2007.10.192. Epub 2007 Nov 9.
6
Assembly of heterohexameric trypanosome hexokinases reveals that hexokinase 2 is a regulable enzyme.锥虫己糖激酶异源六聚体的组装表明己糖激酶2是一种可调节的酶。
J Biol Chem. 2008 May 30;283(22):14963-70. doi: 10.1074/jbc.M802124200. Epub 2008 Apr 3.
7
Inhibitory action of the antitumor agent lonidamine on mitochondrial respiration of Trypanosoma cruzi and T. brucei.
Mol Biochem Parasitol. 1986 Sep;20(3):237-41. doi: 10.1016/0166-6851(86)90104-0.
8
Inhibition of Trypanosoma brucei glucose-6-phosphate dehydrogenase by human steroids and their effects on the viability of cultured parasites.人甾体对布氏锥虫葡萄糖-6-磷酸脱氢酶的抑制作用及其对培养寄生虫活力的影响。
Bioorg Med Chem. 2009 Mar 15;17(6):2483-9. doi: 10.1016/j.bmc.2009.01.068. Epub 2009 Feb 4.
9
Regulation of glycolysis in Trypanosoma brucei: hexokinase and phosphofructokinase activity.布氏锥虫糖酵解的调节:己糖激酶和磷酸果糖激酶活性
Acta Trop. 1982 Mar;39(1):61-72.
10
The Trypanosoma brucei sphingolipid synthase, an essential enzyme and drug target.布氏锥虫鞘脂合成酶,一种必需酶及药物靶点。
Mol Biochem Parasitol. 2009 Nov;168(1):16-23. doi: 10.1016/j.molbiopara.2009.06.002. Epub 2009 Jun 21.

引用本文的文献

1
A multiplexed high throughput screening assay using flow cytometry identifies glycolytic molecular probes in bloodstream form Trypanosoma brucei.一种使用流式细胞术的多重高通量筛选测定法鉴定了布氏锥虫血流形式中的糖酵解分子探针。
Int J Parasitol Drugs Drug Resist. 2024 Dec;26:100557. doi: 10.1016/j.ijpddr.2024.100557. Epub 2024 Aug 8.
2
Discovery of Strong 3-Nitro-2-Phenyl--Chromene Analogues as Antitrypanosomal Agents and Inhibitors of Glucokinase.强效3-硝基-2-苯基-色烯类似物作为抗锥虫剂和葡萄糖激酶抑制剂的发现。
Int J Mol Sci. 2024 Apr 13;25(8):4319. doi: 10.3390/ijms25084319.
3
Comparative Analysis of the Interaction of Silver Nanoparticles with Hexokinase from and Humans.
比较分析纳米银与人源和酵母源己糖激酶的相互作用
Int J Nanomedicine. 2023 Mar 23;18:1399-1411. doi: 10.2147/IJN.S401319. eCollection 2023.
4
Tandem Mass Tagging (TMT) Reveals Tissue-Specific Proteome of L4 Larvae of s. s.: Enzymes of Energy and/or Carbohydrate Metabolism as Potential Drug Targets in Anisakiasis.串联质量标签 (TMT) 揭示了 s.s. L4 幼虫的组织特异性蛋白质组:能量和/或碳水化合物代谢酶作为旋毛虫病潜在的药物靶点。
Int J Mol Sci. 2022 Apr 14;23(8):4336. doi: 10.3390/ijms23084336.
5
Nucleotide sugar biosynthesis occurs in the glycosomes of procyclic and bloodstream form Trypanosoma brucei.核苷酸糖生物合成发生在锥虫的前鞭毛体和血液体形式的糖体中。
PLoS Negl Trop Dis. 2021 Feb 16;15(2):e0009132. doi: 10.1371/journal.pntd.0009132. eCollection 2021 Feb.
6
Repurposing bioenergetic modulators against protozoan parasites responsible for tropical diseases.针对引起热带病的原生动物寄生虫,重新利用生物能量调节剂。
Int J Parasitol Drugs Drug Resist. 2020 Dec;14:17-27. doi: 10.1016/j.ijpddr.2020.07.002. Epub 2020 Jul 22.
7
In vitro effects of lonidamine and 6-aminonicotinamide against Echinococcus granulosussensu stricto and Echinococcus multilocularis.体外洛尼哒胺和 6-氨基烟酰胺对细粒棘球蚴和多房棘球绦虫的作用。
Vet Res. 2020 Feb 26;51(1):29. doi: 10.1186/s13567-020-00744-6.
8
Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance.靶向肿瘤表型可塑性和代谢重编程以适应交叉药物耐受。
Sci Signal. 2019 Aug 20;12(595):eaas8779. doi: 10.1126/scisignal.aas8779.
9
Discovery and Genetic Validation of Chemotherapeutic Targets for Chagas' Disease.发现和遗传验证治疗恰加斯病的化疗靶点。
Front Cell Infect Microbiol. 2019 Jan 7;8:439. doi: 10.3389/fcimb.2018.00439. eCollection 2018.
10
Optimization and Evaluation of Antiparasitic Benzamidobenzoic Acids as Inhibitors of Kinetoplastid Hexokinase 1.作为动质体己糖激酶1抑制剂的抗寄生虫苯甲酰苯甲酸的优化与评价
ChemMedChem. 2017 Dec 7;12(23):1994-2005. doi: 10.1002/cmdc.201700592. Epub 2017 Nov 16.